Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Qiagen N.V. (QGEN)

Qiagen N.V. (QGEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,064,202
  • Shares Outstanding, K 225,509
  • Annual Sales, $ 1,502 M
  • Annual Income, $ 190,380 K
  • 60-Month Beta 0.91
  • Price/Sales 5.38
  • Price/Cash Flow 13.92
  • Price/Book 3.12

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.44
  • Number of Estimates 7
  • High Estimate 0.45
  • Low Estimate 0.43
  • Prior Year 0.40
  • Growth Rate Est. (year over year) +10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
30.23 +18.29%
on 12/26/19
41.63 -14.10%
on 12/20/19
-5.47 (-13.27%)
since 12/17/19
3-Month
27.76 +28.82%
on 10/22/19
43.16 -17.15%
on 12/02/19
+7.58 (+26.90%)
since 10/17/19
52-Week
25.04 +42.81%
on 10/09/19
43.16 -17.15%
on 12/02/19
-0.88 (-2.40%)
since 01/17/19

Most Recent Stories

More News
Global Exome Sequencing Market Report with Profiles of 10X Genomics, Agilent Technologies and Qiagen N.V.

The "Exome Sequencing Market" report has been added to ResearchAndMarkets.com's offering.

QGEN : 35.76 (+4.59%)
QIAGEN Builds on Global Collaboration With Amgen for Companion Diagnostic Development in Non-small Cell Lung Cancer

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a strategic collaboration to develop tissue-based companion diagnostics for Amgen's investigational cancer treatment AMG 510 to identify...

QGEN : 35.76 (+4.59%)
SmarTrend Watching for Potential Pullback in Shares of Qiagen Nv After 1.01% Gain

Qiagen Nv (NYSE:QGEN) traded in a range yesterday that spanned from a low of $34.69 to a high of $35.10. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $34.83...

QGEN : 35.76 (+4.59%)
After Yesterday's Rally of 1.01% Shares Could Potentially Pullback

Qiagen Nv (NYSE:QGEN) traded in a range yesterday that spanned from a low of $34.69 to a high of $35.10. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $34.83...

QGEN : 35.76 (+4.59%)
QIAGEN N.V. to Report Fourth Quarter and Full Year 2019 Results

QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced today that it plans as previously announced to release its report on results for the fourth quarter and full-year 2019 on Tuesday, February...

QGEN : 35.76 (+4.59%)
QIAGEN Celebrates Surpassing 2,500 Cumulative Placements of QIAsymphony

QIAGEN N.V. (NYSE:QGEN; Frankfurt Prime Standard:QIA) today announced the 2,500th placement of QIAsymphony, the leading Sample to Insight workflow automation solution for molecular laboratories worldwide,...

QGEN : 35.76 (+4.59%)
Here's Why You Should Hold on to QIAGEN (QGEN) Stock Now

Investors can retain QIAGEN (QGEN) stock for now, thanks to its solid prospects.

OMCL : 85.93 (-1.82%)
HAE : 113.85 (-1.86%)
QGEN : 35.76 (+4.59%)
WST : 157.59 (-0.49%)
Company News For Dec 27, 2019

Companies In The News Are: QGEN, IMMU, CANF, SBPH

QGEN : 35.76 (+4.59%)
IMMU : 19.00 (-1.78%)
CANF : 2.73 (-0.73%)
SBPH : 1.84 (-1.60%)
Amazon and Immunomedics rise; Qiagen, Hovnanian move lower

NEW YORK (AP) — Stocks that moved substantially or traded heavily on Thursday:

AMZN : 1,864.72 (-0.70%)
IMMU : 19.00 (-1.78%)
HOV : 27.09 (+2.54%)
QGEN : 35.76 (+4.59%)
SPPI : 3.24 (-1.52%)
SmarTrend Watching for Potential Rebound in Shares of Qiagen Nv After 24.96% Loss

Qiagen Nv (NYSE:QGEN) traded in a range yesterday that spanned from a low of $30.23 to a high of $31.64. Yesterday, the shares fell 25.0%, which took the trading range below the 3-day low of $40.92 on...

QGEN : 35.76 (+4.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade QGEN with:

Business Summary

Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.

See More

Key Turning Points

2nd Resistance Point 37.03
1st Resistance Point 36.40
Last Price 35.76
1st Support Level 34.67
2nd Support Level 33.57

See More

52-Week High 43.16
Fibonacci 61.8% 36.24
Last Price 35.76
Fibonacci 50% 34.10
Fibonacci 38.2% 31.96
52-Week Low 25.04

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar